mepivacaine has been researched along with Deafness, Sudden in 1 studies
Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.
Deafness, Sudden: Complete sensorineural hearing loss which develops suddenly over a period of hours or a few days.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, H | 1 |
| Fujimura, T | 1 |
| Ikeda, K | 1 |
| Shiomori, T | 1 |
| Udaka, T | 1 |
| Ohbuchi, T | 1 |
| Nagatani, G | 1 |
1 other study available for mepivacaine and Deafness, Sudden
| Article | Year |
|---|---|
Prostaglandin E1 in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprostadil; Audiometry, Pure-Tone; Auditory Threshold; | 2008 |